About TALZENNA® (talazoparib) TALZENNA is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA ...

In the Phase 3 MagnetisMM-32 trial, ELREXFIO demonstrated a clinically meaningful and statistically significant benefit for ...

Cecile Guegan to lead Pfizer’s financial strategy as Chief Financial Officer with over 25 years of pharmaceutical finance experience NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced ...

Here at Pfizer, we are in the business of breakthroughs, and while our focus is on making advancements that impact patients’ lives, we are also aware of our work’s broader impact on the world. Every ...

Pfizer offers competitive compensation and benefits based on a variety of factors including prior experience, geographic location, and talent pool availability: ...

As Chief Scientific Officer and President, Research & Development, for Pfizer, Inc., Chris Boshoff leads the company’s research and development strategy and execution in all Therapeutic Areas, ...

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned ...

It started with a breakthrough. The year was 1849, and people everywhere were getting sick to their stomachs. In the days before widespread refrigeration, a simple meal of meat and potatoes could ...

Pfizer is a well-established name that’s proud to shape Ireland’s thriving pharmaceuticals industry. We are home to around 3,700 people in six sites in Ireland, delivering skills across manufacturing, ...

We can't wait for you to join us! To help you prepare, we’ve created an onboarding experience that will get you ready for day one, give you an opportunity to learn more about the business, and start ...

Eight years ago, few people had heard of transthyretin amyloid cardiomyopathy (ATTR-CM), and it was rarely diagnosed in cardiology practice. 1,2 Today, it is a treatable condition that cardiologists ...